[HTML][HTML] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease

TF Rehring, RS Stolcpart, BG Sandhoff… - Journal of vascular …, 2006 - Elsevier
OBJECTIVE: Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …

Lipid management and peripheral arterial disease

SS Daskalopoulou, ME Daskalopoulos… - Current Drug …, 2007 - ingentaconnect.com
Peripheral arterial disease (PAD) is a common disorder usually associated with silent or
symptomatic arterial disease elsewhere in the circulation and a “cluster” of cardiovascular …

Peripheral artery disease patients are poorly aware of their disease

IU Builyte, T Baltrunas, E Butkute… - Scandinavian …, 2019 - Taylor & Francis
Objectives. We hypothesized, that patients with peripheral arterial disease (PAD) are less
aware of risk factors and possible outcomes of the disease compared to patients with …

Lipid-lowering treatment in peripheral artery disease

N Katsiki, AD Giannoukas, VG Athyros… - Current opinion in …, 2018 - Elsevier
Highlights•Peripheral artery disease (PAD) is characterized by increased cardiovascular
risk.•Statins remain the first-line lipid-lowering therapy to treat PAD patients.•Statins …

Lipid management in people with peripheral artery disease

J Golledge, NC Ward, GF Watts - Current Opinion in Lipidology, 2019 - journals.lww.com
Effective methods to educate physicians and patients on best medical management are
needed. Further research is needed to examine the benefit of LDL-c lowering and other lipid …

Diagnosis and treatment of peripheral arterial disease compared with other atherosclerotic vascular diseases in a university primary care clinic

HM Ismail, K Jackson, D Smith - Journal of investigative …, 2006 - journals.sagepub.com
Background Despite the fact that peripheral arterial disease (PAD) significantly increases
the risk of cardiovascular mortality, it is significantly underdiagnosed and undertreated. The …

The real-world data of lipid-lowering treatment in patients with peripheral artery disease and its association with severity of disease

H Komai, M Ogura, H Sakashita, N Miyama… - Journal of …, 2024 - Elsevier
Background The risk of coronary artery disease in peripheral arterial disease (PAD) is high,
life prognosis is poor, and lipid-lowering treatment with statins has been reported to improve …

Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease

CH Saely, S Sternbauer, A Vonbank, C Heinzle… - Journal of Diabetes and …, 2020 - Elsevier
Background and aims Patients with peripheral artery disease (PAD) are at a very high risk of
cardiovascular events and strongly benefit from lowering LDL cholesterol (LDL-C); updated …

Medical risk factor treatment in peripheral arterial disease. Need for further improvement.

A Alhadad, C Wictorsson, H Alhadad… - … Angiology: a Journal …, 2013 - europepmc.org
Aim Risk factors for development of peripheral arterial disease (PAD) are the same as for
atherosclerotic coronary or precerebral disease, and patients with PAD have a high …

Peripheral arterial disease is prevalent but underdiagnosed and undertreated in the primary care setting in central Greece

C Argyriou, V Saleptsis, S Koutsias… - Angiology, 2013 - journals.sagepub.com
We investigated the prevalence of peripheral arterial disease (PAD). Primary Care Health
Centers (n= 14) in Thessaly (central Greece) recruited 436 participants, mean age 71 (50 …